Human CD4(+) memory T-lymphocyte responses to SARS coronavirus infection

Area of Science:

• Immunology
• Virology
• Infectious Diseases

Background:

• Severe acute respiratory syndrome (SARS) is caused by the SARS coronavirus.
• Understanding CD4(+) T-cell immunity is crucial for managing SARS-CoV infections.
• Limited data exists on memory T-cell responses to SARS-CoV structural proteins.

Purpose of the Study:

• To investigate the memory CD4(+) T-cell immunity against SARS coronavirus structural proteins in recovered patients.
• To define the specificity and HLA restriction of CD4(+) T-cell responses to SARS-CoV peptides.
• To assess the duration of these immune responses post-infection.

Main Methods:

• Generation of CD4(+) T-cell lines from two SARS patients.
• Testing T-cell responses against peptides from SARS coronavirus structural proteins, including the spike (S) protein.
• Defining HLA restriction for T-cell epitopes.
• Quantifying anti-SARS coronavirus IgG levels and CD4(+) T-cell frequencies at 12 months post-infection.

Main Results:

• CD4(+) T-cell lines recognized three peptides from the SARS-CoV spike protein.
• In one patient, the primary T-cell response targeted an epitope outside the S protein's receptor-binding domain.
• By 12 months post-SARS-CoV infection, both patients exhibited low frequencies of CD4(+) memory T-cells and low anti-SARS-CoV IgG levels.

Conclusions:

• This study provides insights into the specificity of CD4(+) T-cell responses to SARS-CoV.
• The findings suggest that CD4(+) T-cell immunity and antibody levels diminish significantly by 12 months after SARS infection.
• Further research is needed to fully elucidate the long-term T-cell immunity against SARS coronavirus.